How to implement a guideline: From theory to practice - The example of the venous thromboembolism prophylaxis;Como implementar uma diretriz: Da teoria à prática exemplo da profilaxia para tromboembolismo venoso

Acta Medica Portuguesa

Volumn 22, Issue 1, 2009, Pages 21-32

  Paiva, Edison F ^a   Rocha, Ana T C ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; CLINICAL PRACTICE; FIBRINOLYSIS; HUMAN; MEDICAL AUDIT; MEDICAL EDUCATION; MEDICAL SOCIETY; PATIENT CARE; PATIENT SAFETY; PRACTICE GUIDELINE; PRESCRIPTION; REVIEW; THROMBOSIS PREVENTION; TOTAL QUALITY MANAGEMENT; VENOUS THROMBOEMBOLISM; ALGORITHM; ARTICLE; EVIDENCE BASED MEDICINE; FIBRINOLYTIC THERAPY; HEALTH CARE PLANNING; HOSPITALIZATION; INFORMATION DISSEMINATION; LUNG EMBOLISM; METHODOLOGY; ORGANIZATION AND MANAGEMENT; STANDARD; TIME; VEIN THROMBOSIS;

ALGORITHMS; EVIDENCE-BASED MEDICINE; GUIDELINE ADHERENCE; HEALTH PLAN IMPLEMENTATION; HOSPITALIZATION; HUMANS; INFORMATION DISSEMINATION; PRACTICE GUIDELINES AS TOPIC; PULMONARY EMBOLISM; THROMBOLYTIC THERAPY; TIME FACTORS; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 68849088286     PISSN: None     EISSN: 16460758     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. FLETCHER AP, ALKJAERSIG N, SMYRNIOTIS FE, SHERRY S: The treatment of patients suffering from early myocardial infarction with massive and prolonged streptokinase therapy. Trans Assoc Am Physicians 1958;71:287-296
2. YUSUF S, COLLINS R, PETO R et al: Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J 1985;6:556-85
3. BALAS E, BOREN SA: Managing Clinical Knowledge for Health Care Improvement. In: Bemmel J, McCray AT, editors. Yearbook of Medical Informatics: Patient-Centered Systems. Stuttgart, Germany: Schattauer Verlagsgesellschaft mbH 2000;65-70
4. MCGLYNN EA, ASCH SM, ADAMS J et al: The quality of health care delivered to adults in the United States. N Engl J Med 2003;348:2635-45
5. CAPRINI JA, HYERS TM: Compliance with antithrombotic guidelines. Manag Care 2006;15:49-66
6. KAWAMOTO K, HOULIHAN CA, BALAS EA, LOBACH DF: Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ 2005;330:740-1
7. TOOHER R, MIDDLETON P, PHAM C et al: A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals. Ann Surg 2005;241:397-415
8. a ed. Rio de Janeiro: MEDSI 2002;1363-86
9. LINDBLAD B, STERNBY NH, BERGQVIST D: Incidence of Venous Thromboembolism Verified by Necropsy Over 30 Years. BMJ 1991;302:700-2
10. MAFFEI FHA, FALLEIROS ATD, VENEZIAN CA, FRANCO MF: Contribuiç ão ao Estudo da Incidência e Anatomia Patológica do Tromboembolismo Pulmonar em Autópsias. Rev Ass Med Bras 1980;26:7-10
11. SANDLER DA, MARTIN JF: Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis. J R Soc Med 1989;82:203-5
12. GOLDHABER SZ, TAPSON VF, DVT FREE Steering Committee: A prospective registry of 5,451 patients with ultrasoundconfirmed deep vein thrombosis. Am J Cardiol 2004;93:259-262
13. CHOPARD P, DÖRFFLER-MELLY J, HESS U et al: Venous thromboembolism prophylaxis in acutely ill medical patients: definite need for improvement. J Intern Med 2005;257:352-7
14. ROCHA AT, BRAGA P, RITT G, LOPES AA: Inadequacy of thromboprophylaxis in hospitalized medical patients. Rev Assoc Med Bras 2006;52:441-6
15. Tromboembolismo Venoso: Profilaxia em Pacientes Clínicos - Partes I a III. Disponível em: http://www.projetodiretrizes.org.br/volume-4.php [Acedido em ....]
16. GEERTS WH, PINEO GF, HEIT JA et al: Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;3(Suppl.):338S-400S
17. Cardiovascular Disease Educational and Research Trust; Cyprus Cardiovascular Disease Educational and Research Trust; European Venous Forum; International Surgical Thrombosis Forum; International Union of Angiology; Union Internationale de Phlebologie: Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence). Int Angiol 2006;25:101-161
18. CABANA MD, RAND CS, POWE NR et al: Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999;282:1458-65
19. MISMETTI P, LAPORTE-SIMITSIDIS S, TARDY B et al: Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomized clinical trials. Thromb Haemost 2000;83:14-9
20. DENTALI F, DOUKETIS JD, GIANNI M, LIM W, CROWTHER MA: Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med 2007;146:278-288
21. KAHN SR, GINSBERG JS: The post-thrombotic syndrome: current knowledge, controversies, and directions for future research. Blood Rev 2002;16:155-165
22. KAHN SR, ELMAN E, RODGER MA, WELLS PS: Use of elastic compression stockings after deep venous thrombosis: a comparison of practices and perceptions of thrombosis physicians and patients. J Thromb Haemost 2003;1:500-6
23. KAHN SR, ELMAN EA, BORNAIS C, BLOSTEIN M, WELLS PS: Post-thrombotic syndrome, functional disability and quality of life after upper extremity deep venous thrombosis in adults. Thromb Haemost 2005;93:499-502
24. ARCELUS JI, CAPRINI JA, TRAVERSO CI: Venous thromboembolism after hospital discharge. Semin Thromb Hemost 1993;19(Suppl 1):142-6
25. SCHADLICH PK, KENTSCH M, WEBER M et al: Cost effectiveness of enoxaparin as prophylaxis against venous thromboembolic complications in acutely ill medical inpatients: modeling study from the hospital perspective in Germany. Pharmacoeconomics 2006;24:571-591
26. MCGARRY LJ, THOMPSON D, WEINSTEIN MC, GOLDHABER SZ: Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients. Am J Manag Care 2004;10:632-642
27. TILLEUL P, LAFUMA A, COLIN X, OZIER Y: Estimated annual costs of prophylaxis and treatment of venous thromboembolic events associated with major orthopedic surgery in France. Clin Appl Thromb Hemost 2006;12:473-484
28. GEROTZIAFAS GT, SAMAMA MM: Prophylaxis of venous thromboembolism in medical patients. Curr Opin Pulm Med 2004;10:356-65
29. Making Health Care Safer: A Critical Analysis of Patient Safety Practices. Available from: http://www.ahrq.gov/clinic/ptsafety [Acedido em...]
30. FRANCIS CW: Prophylaxis for Thromboembolism in Hospitalized Medical Patients. N Engl J Med 2007;356:1438-44
31. Performance Measurement Initiatives: National Consensus Standards for Prevention and Care of Venous Thromboembolism (VTE). Available from: http://www.jointcommission.org/ PerformanceMeasurement/PerformanceMeasurement/ VTE.htm.
32. BORBAS C, MORRIS N, MCLAUGHLIN B, ASINGER R, GOBEL F: The Role of Clinical Opinion Leaders in Guideline Implementation and Quality Improvement. Chest 2000;118(2 Suppl):24S-32S.
33. KUCHER N, KOO S, QUIROZ R, COOPER JM et al: Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 2005;352:969-77